{"id":65763,"date":"2025-12-21T11:41:17","date_gmt":"2025-12-21T06:11:17","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=65763"},"modified":"2025-12-21T11:41:20","modified_gmt":"2025-12-21T06:11:20","slug":"doacs-vs-warfarin-understanding-the-key-pharmacological-differences","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/","title":{"rendered":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/sw8EItm4VFM?si=1LM3NwTAjnNXc9xL\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">In the management of thromboembolic disorders, the pharmacological landscape has shifted significantly from the traditional use of <strong>Warfarin<\/strong> (a Vitamin K Antagonist) to <strong>Direct Oral Anticoagulants (DOACs)<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The primary difference lies in their precision: Warfarin acts like a &#8220;shotgun,&#8221; broadly suppressing the synthesis of multiple clotting factors, whereas DOACs act like a &#8220;sniper,&#8221; targeting a single specific protein in the coagulation cascade.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">1. Mechanism of Action<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The most fundamental difference is how these drugs prevent clot formation.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Warfarin (Indirect):<\/strong> It is a <strong>Vitamin K Antagonist (VKA)<\/strong>. It inhibits the key enzyme <em>Vitamin K epoxide reductase<\/em> This prevents the liver from synthesizing functional <strong>Factors II, VII, IX, and X<\/strong>, as well as the anticoagulant proteins C and S.<\/li>\n\n\n\n<li class=\"\"><strong>DOACs (Direct):<\/strong> These drugs bypass the synthesis stage and bind directly to active clotting factors already in the blood.\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Direct Thrombin Inhibitors:<\/strong> Dabigatran binds to <strong>Factor IIa (Thrombin)<\/strong>.<\/li>\n\n\n\n<li class=\"\"><strong>Factor Xa Inhibitors:<\/strong> Rivaroxaban, Apixaban, and Edoxaban bind to <strong>Factor Xa<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2. Pharmacokinetics and Dynamics<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">DOACs were designed to address the unpredictable nature of Warfarin therapy.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Feature<\/strong><\/td><td><strong>Warfarin<\/strong><\/td><td><strong>DOACs<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>Onset of Action<\/strong><\/td><td>Slow (3\u20135 days to reach therapeutic levels)<\/td><td>Rapid (1\u20134 hours to peak effect)<\/td><\/tr><tr><td><strong>Offset of Action<\/strong><\/td><td>Long (days)<\/td><td>Short (12\u201324 hours)<\/td><\/tr><tr><td><strong>Dosing<\/strong><\/td><td>Variable; requires frequent adjustment<\/td><td>Fixed dosing<\/td><\/tr><tr><td><strong>Monitoring<\/strong><\/td><td>Required (INR blood tests)<\/td><td>Not required routinely<\/td><\/tr><tr><td><strong>Drug\/Food Interactions<\/strong><\/td><td>Extensive (Vitamin K intake, many medications)<\/td><td>Minimal<\/td><\/tr><tr><td><strong>Half-life<\/strong><\/td><td>Long (approximately 40 hours)<\/td><td>Short (7\u201315 hours)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3. Clinical Considerations &amp; Limitations<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">While DOACs are often preferred for convenience, they are not universally superior.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Where Warfarin Still Wins:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Mechanical Heart Valves:<\/strong> Warfarin remains the gold standard. DOACs (specifically Dabigatran) were found to be inferior and potentially dangerous in patients with mechanical valves.<\/li>\n\n\n\n<li class=\"\"><strong>Severe Renal Failure:<\/strong> Warfarin is metabolized primarily by the liver, making it safer for patients with end-stage renal disease (ESRD). DOACs rely on renal clearance to varying degrees (Dabigatran being the most renal-dependent). In this context, it is worth noting that warfarin use is strongly associated with accelerating and increasing arterial calcification, including in coronary and peripheral arteries. That is by inhibiting Matrix Gla Protein (MGP), a natural inhibitor of calcium buildup, leading to potential cardiovascular complications.<\/li>\n\n\n\n<li class=\"\"><strong>Cost:<\/strong> Warfarin is significantly less expensive, though the cost of frequent INR monitoring can offset this.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Where DOACs Excel:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Safety Profile:<\/strong> DOACs generally show a lower risk of <strong>intracranial hemorrhage<\/strong> compared to Warfarin.<\/li>\n\n\n\n<li class=\"\"><strong>Lifestyle:<\/strong> No &#8220;green leafy vegetable&#8221; restrictions and no need for monthly clinic visits for blood draws.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4. Reversibility<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Historically, Warfarin was preferred because its effects could be reversed quickly with <strong>Vitamin K<\/strong> or <strong>Prothrombin Complex Concentrate (PCC)<\/strong>. Today, specific &#8220;antidotes&#8221; exist for DOACs as well:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Idarucizumab:<\/strong> Reverses Dabigatran.<\/li>\n\n\n\n<li class=\"\"><strong>Andexanet Alfa:<\/strong> Reverses Factor Xa inhibitors (Apixaban and Rivaroxaban).<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Summary Checklist<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Choose DOACs for:<\/strong> Convenience, lower brain-bleed risk, and non-valvular atrial fibrillation.<\/li>\n\n\n\n<li class=\"\"><strong>Choose Warfarin for:<\/strong> Mechanical heart valves, severe kidney disease, or when cost is the primary barrier.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>In the management of thromboembolic disorders, the pharmacological landscape has shifted significantly from the traditional use of Warfarin (a Vitamin K Antagonist) to Direct Oral Anticoagulants (DOACs). The primary difference lies in their precision: Warfarin acts like a &#8220;shotgun,&#8221; broadly suppressing the synthesis of multiple clotting factors, whereas DOACs act like a &#8220;sniper,&#8221; targeting a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":65764,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-65763","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"In the management of thromboembolic disorders, the pharmacological landscape has shifted significantly from the traditional use of Warfarin (a Vitamin K Antagonist) to Direct Oral Anticoagulants (DOACs). The primary difference lies in their precision: Warfarin acts like a &#8220;shotgun,&#8221; broadly suppressing the synthesis of multiple clotting factors, whereas DOACs act like a &#8220;sniper,&#8221; targeting a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-21T06:11:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-21T06:11:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"678\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences\",\"datePublished\":\"2025-12-21T06:11:17+00:00\",\"dateModified\":\"2025-12-21T06:11:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/\"},\"wordCount\":471,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/\",\"name\":\"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg\",\"datePublished\":\"2025-12-21T06:11:17+00:00\",\"dateModified\":\"2025-12-21T06:11:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg\",\"width\":1200,\"height\":678},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/","og_locale":"en_US","og_type":"article","og_title":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders","og_description":"In the management of thromboembolic disorders, the pharmacological landscape has shifted significantly from the traditional use of Warfarin (a Vitamin K Antagonist) to Direct Oral Anticoagulants (DOACs). The primary difference lies in their precision: Warfarin acts like a &#8220;shotgun,&#8221; broadly suppressing the synthesis of multiple clotting factors, whereas DOACs act like a &#8220;sniper,&#8221; targeting a [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2025-12-21T06:11:17+00:00","article_modified_time":"2025-12-21T06:11:20+00:00","og_image":[{"width":1200,"height":678,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences","datePublished":"2025-12-21T06:11:17+00:00","dateModified":"2025-12-21T06:11:20+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/"},"wordCount":471,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/","url":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/","name":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg","datePublished":"2025-12-21T06:11:17+00:00","dateModified":"2025-12-21T06:11:20+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2025\/12\/DOACs-vs.-Warfarin-Understanding-the-Key-Pharmacological-Differences.jpg","width":1200,"height":678},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/doacs-vs-warfarin-understanding-the-key-pharmacological-differences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"DOACs vs. Warfarin: Understanding the Key Pharmacological Differences"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/65763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=65763"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/65763\/revisions"}],"predecessor-version":[{"id":65765,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/65763\/revisions\/65765"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/65764"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=65763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=65763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=65763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}